跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AURO-SITAGLIPTIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
AURO-SITAGLIPTIN
Authorized
STANDARD
AURO-SITAGLIPTIN
auro pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
853dc126c7e55078
Company
auro pharma inc
Type
Standard
Approval Details
Approval Id
853dc126c7e55078
Drug Approval Canada Name
AURO-SITAGLIPTIN
Product Name
AURO-SITAGLIPTIN
Status
Marketed
Status Date
2023-01-05
Original Market Date
2023-01-05
Din
02529882
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
68:20.05
Atc Original
A10BH01 SITAGLIPTIN
Atc Name
a 10 bh 01
Aig Number
0152414001
Company Name
auro pharma inc
Company Address
3700 Steeles Avenue West, Suite 402, Woodbridge, Ontario, Canada, L4L 8K8
Active Ingredients
SITAGLIPTIN (SITAGLIPTIN HYDROCHLORIDE MONOHYDRATE)
100 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
853dc126c7e55078
Type
Standard
Back to Health Canada Approvals